Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors
Clinical Trial Grant
Duke Scholars
Principal Investigator
Tian Zhang
Medicine, Medical Oncology
Awarded By
AbbVie Inc.
Start Date
October 3, 2017
End Date
November 20, 2020
Awarded By
AbbVie Inc.
Start Date
October 3, 2017
End Date
November 20, 2020
